secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001193125-26-161800
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines issues $500M 0.50% convertible notes due 2033
------------------------------------------------------------------

- Issued $500M 0.50% Convertible Senior Notes due 2033 under indenture with U.S. Bank Trust as trustee.
- Initial conversion price ~$198.80/share (5.0302 shares per $1,000 principal).
- Notes are senior unsecured, redeemable after May 2030 if stock >130% conversion price for 20 of 30 trading days.
- Holders may convert before Feb 2033 only upon specified events; after that anytime until maturity.
- Fundamental change triggers repurchase right at 100% principal plus accrued interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312526161800/0001193125-26-161800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312526161800/d19920d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-161800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer